Epizyme, Inc.

VANGUARD GROUP INC

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/12/2022

Shares

7,540,469

Value ($000)

11,084

Weight

0.0%

2013 Q4 - 2022 Q2 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/12/2022	11,084	0.0%	7,540,469	6/30/2022
2022 Q1	5/13/2022	8,568	0.0%	7,450,156	3/31/2022
2021 Q4	2/14/2022	14,962	0.0%	5,984,908	12/31/2021
2021 Q3	11/12/2021	40,234	0.0%	7,858,273	9/30/2021
2021 Q2	8/13/2021	65,659	0.0%	7,901,309	6/30/2021
2021 Q1	5/14/2021	68,199	0.0%	7,829,978	3/31/2021
2020 Q4	2/12/2021	82,158	0.0%	7,565,247	12/31/2020
2020 Q3	11/16/2020	87,579	0.0%	7,341,130	9/30/2020
2020 Q2	8/14/2020	115,808	0.0%	7,210,960	6/30/2020
2020 Q1	5/15/2020	108,372	0.0%	6,987,192	3/31/2020
2019 Q4	2/14/2020	167,436	0.0%	6,806,333	12/31/2019
2014 Q2	8/11/2014	22,149	0.0%	711,732	6/30/2014
2014 Q1	5/13/2014	15,646	0.0%	687,116	3/31/2014
2013 Q4	2/12/2014	5,332	0.0%	256,341	12/31/2013